Form 4: TBRG Insider David Harse Disposes of 1,744 Shares

Rhea-AI Filing Summary

Insider sale disclosed: The filing shows that David Harse, listed as an officer with the title General Manager Patient Care, reported a sale of 1,744 shares of TruBridge, Inc. (TBRG) on 03/14/2025 at a reported price of $27.40 per share. After the transaction he beneficially owned 18,058 shares, held directly. The form is signed by an attorney by power of attorney on 08/15/2025. No derivative transactions or additional remarks are included in the filing.

Positive

• None.

Negative

• Insider sale reported: Officer David Harse sold 1,744 shares at $27.40 on 03/14/2025.
• No contextual disclosure: The filing contains no remarks indicating a trading plan (e.g., Rule 10b5-1) or reason for the sale.

Insights

Securities Analyst

TL;DR: Routine insider sale disclosed; size appears modest relative to a single officer's holdings and contains no derivatives or complications.

The report documents a straightforward sale of 1,744 shares by an officer of TruBridge at $27.40 per share with 18,058 shares remaining beneficially owned. There are no derivative positions reported and no explanatory remarks about the reason for the sale or a Rule 10b5-1 plan. For investors, this is a standard Section 16 disclosure that updates insider holdings but does not, by itself, provide evidence of company-level material change.

Corporate Governance Expert

TL;DR: Disclosure meets basic Section 16 requirements; lacks context on intent or trading plan.

The Form 4 shows required disclosure of beneficial ownership change and is signed under power of attorney. The filing does not indicate the transaction was made under a 10b5-1 plan or provide any explanatory remarks, which limits context for governance assessment. As filed, it fulfills reporting obligations but gives no information about whether the sale was pre-planned or opportunistic.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harse David

(Last) (First) (Middle)

54 ST. EMANUEL STREET

(Street)

MOBILE AL 36602

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TruBridge, Inc. [ TBRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Manager Patient Care

3. Date of Earliest Transaction (Month/Day/Year)
03/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/14/2025		S		1,744	D	$27.4	18,058	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Christopher L. Fowler, by power of attorney	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did David Harse report on the Form 4 for TBRG?

He reported a sale of 1,744 shares of TruBridge (TBRG) on 03/14/2025 at $27.40 per share.

How many TruBridge shares does the reporting person own after the reported sale?

The filing shows the reporting person beneficially owned 18,058 shares following the transaction.

Was any derivative security disclosed in this Form 4 for TBRG?

No. The filing contains no entries in Table II for derivative securities.

Does the Form 4 state whether the sale was made under a 10b5-1 trading plan?

No. The filing does not indicate

When was the Form 4 signed and by whom?

The document is signed by Christopher L. Fowler, by power of attorney on 08/15/2025.